Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced it is pledging $7.8 million to the ‘Fund our Futures’ campaign led by ...

Pfizer (PFE) stock in focus as company is eyeing to sell its hospital drugs unit, Pfizer Hospital, potentially worth billions ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

after Pfizer acquired Array in 2019. Thomas also held leadership posts with Novartis, Bristol-Myers Squibb, Beigene, GSK and ...